Guided Therapeutics, Inc.
GTHP
$0.20
-$0.03-12.28%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -500.00K | -1.22M | -742.00K | -809.00K | -427.00K |
| Total Depreciation and Amortization | 24.00K | 28.00K | 27.00K | 27.00K | 25.00K |
| Total Amortization of Deferred Charges | 48.00K | 55.00K | 54.00K | 68.00K | 67.00K |
| Total Other Non-Cash Items | -81.00K | 366.00K | 160.00K | 272.00K | -10.00K |
| Change in Net Operating Assets | -108.00K | 478.00K | 224.00K | 273.00K | 14.00K |
| Cash from Operations | -617.00K | -291.00K | -277.00K | -169.00K | -331.00K |
| Capital Expenditure | -- | 0.00 | -2.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | -2.00K | -- | -- |
| Total Debt Issued | 188.00K | 125.00K | 63.00K | 355.00K | -- |
| Total Debt Repaid | -217.00K | -197.00K | -125.00K | -71.00K | -147.00K |
| Issuance of Common Stock | 980.00K | 307.00K | 260.00K | -- | 205.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -28.00K | 32.00K | -17.00K | -45.00K | -- |
| Cash from Financing | 923.00K | 267.00K | 181.00K | 239.00K | 58.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 306.00K | -24.00K | -98.00K | 70.00K | -273.00K |